Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury
Mindmaze SA
135 participants
Feb 15, 2023
INTERVENTIONAL
Conditions
Summary
Stroke is the leading cause of long-term disability with an increasing incidence, especially in young adults. Among the cognitive difficulties following brain damage, deficits in attention are frequent and pervasive, affecting between 46% and 92% of stroke survivors. The current project targets patients with acquired brain injury, including stroke, traumatic brain injury, and brain tumor. The main objective of this study is to evaluate the use and the efficacy of a training program targeting attention and executive function difficulties, using gamified and digitized versions in virtual reality of standard cognitive exercises for patients with brain lesions.
Eligibility
Inclusion Criteria5
- Time from stroke onset < 1 month
- Objective pathological performance on at least one standardized test or subtest on attention during standard neuropsychological evaluation
- Brain injury documented by routine neuroradiological examination (computed tomography or magnetic resonance imaging scan)
- Able to give informed consent as documented by signature
- Age >= 18 years old
Exclusion Criteria7
- Epilepsy
- Inability or contraindications to undergo the investigated intervention
- Major psychiatric co-morbidity
- Major neurocognitive deficits (e.g. dementia)
- Incapacity to discriminate colors
- General cognitive state preventing to understand and perform the tasks
- Decision to not be informed of incidental findings
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This intervention will include 20 sessions of training with the experimental rehabilitation program using immersive VR cognitive gamified activities, in addition to the standard of care.
This intervention will include 20 sessions of training using a standard neuropsychological rehabilitation program, in addition to the standard of care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05728840